• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1987年至1996年2型糖尿病发病率的快速上升:圣安东尼奥心脏研究结果

Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.

作者信息

Burke J P, Williams K, Gaskill S P, Hazuda H P, Haffner S M, Stern M P

机构信息

Department of Medicine, University of Texas Health Science Center at San Antonio, 78284-7873, USA.

出版信息

Arch Intern Med. 1999 Jul 12;159(13):1450-6. doi: 10.1001/archinte.159.13.1450.

DOI:10.1001/archinte.159.13.1450
PMID:10399896
Abstract

BACKGROUND

The prevalence of type 2 diabetes has increased in the early part of the 20th century, particularly in developing countries. There is now evidence that the prevalence also continues to increase in developed countries, including the United States. However, it is unknown whether this increase is due to a rise in the incidence of diabetes or to decreasing diabetic mortality or both.

METHODS

Participants in the San Antonio Heart Study, who were nondiabetic at baseline and who returned for a 7- to 8-year follow-up examination, were examined for secular trends in the incidence of type 2 diabetes. Risk factors for diabetes, such as obesity, were also examined. Patients were enrolled in the San Antonio Heart Study from 1979 to 1988 and 7- to 8-year incidence of diabetes was determined from 1987 to 1996.

RESULTS

A significant secular trend in the 7- to 8-year incidence of type 2 diabetes was observed in Mexican Americans (5.7% for participants enrolled in 1979 to 15.7% for participants enrolled in 1988). In non-Hispanic whites, the incidence increased from 2.6% for participants enrolled in 1980 to 9.4% for participants enrolled in 1988 (P = .07) . After adjusting for age and sex, the secular trend remained significant in Mexican Americans and borderline significant in non-Hispanic whites. This indicates that between 1987 and 1996 the 7- to 8-year incidence of type 2 diabetes approximately tripled in both ethnic groups. The overall secular trend also remained significant after adjusting for additional risk factors for diabetes, such as obesity. A rising secular trend in obesity was also observed.

CONCLUSIONS

There has been a significant increasing secular trend in the incidence of type 2 diabetes in Mexican Americans and a borderline significant trend in non-Hispanic whites participating in the San Antonio Heart Study. Unlike other cardiovascular risk factors such as lipid levels, cigarette smoking, and blood pressure, which are either declining or under progressively better medical management and control, and unlike cardiovascular mortality, which is also declining, obesity and type 2 diabetes are exhibiting increasing trends. Thus, obesity and diabetes could easily become the preeminent US public health problem.

摘要

背景

20世纪初2型糖尿病的患病率有所上升,尤其是在发展中国家。现在有证据表明,包括美国在内的发达国家的患病率也在持续上升。然而,尚不清楚这种上升是由于糖尿病发病率的上升,还是糖尿病死亡率的下降,抑或是两者兼而有之。

方法

圣安东尼奥心脏研究的参与者在基线时无糖尿病,并返回进行7至8年的随访检查,以研究2型糖尿病发病率的长期趋势。还对肥胖等糖尿病危险因素进行了检查。患者于1979年至1988年参加圣安东尼奥心脏研究,并于1987年至1996年确定了7至8年的糖尿病发病率。

结果

在墨西哥裔美国人中观察到2型糖尿病7至8年发病率有显著的长期趋势(1979年入组的参与者为5.7%,1988年入组的参与者为15.7%)。在非西班牙裔白人中,发病率从1980年入组的参与者的2.6%上升到1988年入组的参与者的9.4%(P = 0.07)。在调整年龄和性别后,墨西哥裔美国人的长期趋势仍然显著,非西班牙裔白人则接近显著。这表明在1987年至1996年期间,两个种族群体中2型糖尿病的7至8年发病率大约增加了两倍。在调整了肥胖等其他糖尿病危险因素后,总体长期趋势仍然显著。肥胖的长期趋势也在上升。

结论

在参加圣安东尼奥心脏研究的墨西哥裔美国人中,2型糖尿病发病率有显著上升的长期趋势,在非西班牙裔白人中则有接近显著的趋势。与其他心血管危险因素如血脂水平、吸烟和血压不同,后者要么在下降,要么在逐步改善的医疗管理和控制之下,也与心血管死亡率的下降不同,肥胖和2型糖尿病呈现上升趋势。因此,肥胖和糖尿病很容易成为美国首要的公共卫生问题。

相似文献

1
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.1987年至1996年2型糖尿病发病率的快速上升:圣安东尼奥心脏研究结果
Arch Intern Med. 1999 Jul 12;159(13):1450-6. doi: 10.1001/archinte.159.13.1450.
2
Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study.墨西哥裔美国人与非西班牙裔白人高血压的八年发病率。圣安东尼奥心脏研究。
Am J Hypertens. 1992 Mar;5(3):147-53. doi: 10.1093/ajh/5.3.147.
3
Migration status, socioeconomic status, and mortality rates in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study.墨西哥裔美国人与非西班牙裔白人的移民身份、社会经济地位及死亡率:圣安东尼奥心脏研究
Ann Epidemiol. 1996 Jul;6(4):307-13. doi: 10.1016/s1047-2797(96)00026-9.
4
Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study.吸烟、糖尿病、高胆固醇和高血压对墨西哥裔美国人全因死亡率和心血管疾病死亡率的影响。圣安东尼奥心脏研究。
Am J Epidemiol. 1996 Dec 1;144(11):1058-65. doi: 10.1093/oxfordjournals.aje.a008878.
5
Prevalence of hypertension in Hispanic and non-Hispanic white populations.西班牙裔和非西班牙裔白人人群中高血压的患病率。
Hypertension. 2002 Feb;39(2):203-8. doi: 10.1161/hy0202.103439.
6
Increased incidence of type II diabetes mellitus in Mexican Americans.墨西哥裔美国人中II型糖尿病发病率上升。
Diabetes Care. 1991 Feb;14(2):102-8. doi: 10.2337/diacare.14.2.102.
7
Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study.墨西哥裔美国人与非西班牙裔白人中的心肌梗死。圣安东尼奥心脏研究。
Circulation. 1991 Jan;83(1):45-51. doi: 10.1161/01.cir.83.1.45.
8
Reversion from type 2 diabetes to nondiabetic status. Influence of the 1997 American Diabetes Association criteria.从2型糖尿病恢复至非糖尿病状态。1997年美国糖尿病协会标准的影响。
Diabetes Care. 1998 Aug;21(8):1266-70. doi: 10.2337/diacare.21.8.1266.
9
All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox".圣安东尼奥心脏研究中墨西哥裔美国人和非西班牙裔白人老年参与者的全因死亡率和心血管死亡率——反对“西班牙裔悖论”的证据
Am J Epidemiol. 2003 Dec 1;158(11):1048-57. doi: 10.1093/aje/kwg249.
10
Lower hypertension risk in Mexico City than in San Antonio.墨西哥城的高血压风险低于圣安东尼奥。
Am J Hypertens. 2005 Mar;18(3):385-91. doi: 10.1016/j.amjhyper.2004.10.022.

引用本文的文献

1
Early Recognition of Overweight Hyperglycaemia May Improve Clinical Outcomes in Type 2 Diabetes.早期识别超重高血糖可能改善2型糖尿病的临床结局。
touchREV Endocrinol. 2023 May;19(1):33-37. doi: 10.17925/EE.2023.19.1.33. Epub 2023 Mar 27.
2
Hydroxynonenal causes Langerhans cell degeneration in the pancreas of Japanese macaque monkeys.羟壬烯醛可致食蟹猴胰岛朗格汉斯细胞变性。
PLoS One. 2021 Nov 8;16(11):e0245702. doi: 10.1371/journal.pone.0245702. eCollection 2021.
3
A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives.
2型糖尿病流行病学、病因学、发病机制、治疗及未来展望的当前趋势综述
Diabetes Metab Syndr Obes. 2021 Aug 10;14:3567-3602. doi: 10.2147/DMSO.S319895. eCollection 2021.
4
Further evidence supporting a potential role for ADH1B in obesity.进一步的证据支持 ADH1B 在肥胖中的潜在作用。
Sci Rep. 2021 Jan 21;11(1):1932. doi: 10.1038/s41598-020-80563-z.
5
Predicting mortality in critically ill patients with diabetes using machine learning and clinical notes.使用机器学习和临床记录预测危重症糖尿病患者的死亡率。
BMC Med Inform Decis Mak. 2020 Dec 30;20(Suppl 11):295. doi: 10.1186/s12911-020-01318-4.
6
Prevalence of pre-diabetes and undiagnosed diabetes in the Mollerussa prospective observational cohort study in a semi-rural area of Catalonia.在加泰罗尼亚半农村地区的莫勒鲁萨前瞻性观察队列研究中,糖尿病前期和未诊断糖尿病的患病率。
BMJ Open. 2020 Jan 20;10(1):e033332. doi: 10.1136/bmjopen-2019-033332.
7
Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test.使用口服葡萄糖耐量试验的支持向量机预测长期 2 型糖尿病。
PLoS One. 2019 Dec 11;14(12):e0219636. doi: 10.1371/journal.pone.0219636. eCollection 2019.
8
Impaired Glucose Tolerance in Adults with Duchenne and Becker Muscular Dystrophy.成人杜氏肌营养不良症和贝克肌营养不良症患者的葡萄糖耐量受损。
Nutrients. 2018 Dec 7;10(12):1947. doi: 10.3390/nu10121947.
9
Sleep-Disordered Breathing and Prevalent Albuminuria in Hispanics/Latinos.西班牙裔/拉丁裔人群中的睡眠呼吸障碍与白蛋白尿症患病率
Kidney Int Rep. 2018 Jun 23;3(6):1276-1284. doi: 10.1016/j.ekir.2018.06.005. eCollection 2018 Nov.
10
The All-Cause Mortality and a Screening Tool to Determine High-Risk Patients among Prevalent Type 2 Diabetes Mellitus Patients.全因死亡率与筛查工具用于确定 2 型糖尿病患者中的高危人群。
J Diabetes Res. 2018 Jul 11;2018:4638327. doi: 10.1155/2018/4638327. eCollection 2018.